MARYAM OYEFUSI: Open Payments
NPI 1538853270 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$83 in 4 payments from 4 companies in 2025. Trend: 2023 $42 · 2024 $154 · 2025 $83
Food & beverage: $83
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| SK Life Science, Inc. | 1 | $18 |
| Averitas Pharma Inc. | 1 | $16 |
Products named: Nayzilam, AUSTEDO XR, QUTENZA.
Industry payments across PA — which companies pay providers there.
